(0.8 ml) to the column and eluted with the same buffer at a flow rate of 5 .4 ml/h. Fractions (1 .35 ml) were collected and tested for TNF-a INH activity .
FPLC Chromatofocusing. Chromatofocusing was performed with a Mono P prepacked column (HR 5/20, 5 X 200 mm; Pharmacia Fine Chemicals) equilibrated in 25 mM Bis- Tris buffer adjusted to pH 7.1 with iminodiacetic acid (Fluka, Buchs, Switzerland). 30 mg of protein was applied to the column and eluted with a polybuffer 74/iminodiacetic acid at pH 4.0. The actual pH of each fraction (1 ml) was determined with a pH meter, and TNF-a INH inactivity was evaluated .
Trypsin Digestion. 50 Ecl of trypsin (10 mg/ml) (Sigma Chemical Co., St. Louis, MO) in 0.2 M Tris-HCl buffer, pH 8.0, containing 1 mM calcium chloride was added to 500 A1 of Sephacryl S-200 semipurified urine dialyzed against the above-mentioned buffer. After 4 h of incubation at 37°C, a second 50-Al sample of trypsin was added to the digestion mixture . The reaction was terminated after 24 h by adding 100 1l soybean trypsin inhibitor (20 mg/ml) (Sigma Chemical Co.). Trypsin digest and controls were tested at a 1 :20 final dilution on L929 cells and in the presence of hrTNF-a at 0.2 ng/ml concentration .
Results
Identification of a Urine-derived TNF-a INH Activity.
Amicon-concentrated and ammonium sulfate-precipitated urine (40-80%) showed TNF-a INH activity when tested in a cytotoxicity assay with the TNF-susceptible cell line L929 in the presence of actinomycin D. Thus, at a 1 :20 final urine dilution, total inhibition of the cytotoxic effect induced by hrTNF-a was observed so that OD570 value was identical to that measured in the presence of actinomycin D alone (OD570 = 1 .5) . Moreover, this material showed inhibitory activity in urine dilutions of up to 1 :160 on cells (OD570 = 0.83) whereas control value of hrTNFa at a final concentration of 0 .2 ng/ml measured in the presence of actinomycin D was lower (013570 = 0.73), so that 50% of inhibition was observed at a dilution of^-1 :100 (013570 -1 .10) . The TNF-a INH had no effect on cell viability when tested without actinomycin D (data not shown) .
Characterization of the Urinary TNF-a INH. Salt-precipitated urine was subjected to Sephacryl S-200 gel filtration . The inhibitory activity was eluted from the gel in a single peak and maximal inhibitory activity showed an apparent molecular mass of 40-60 kD (Fig. 1) . In another experiment, the salt-precipitated urine was chromatofocused on a Mono-P HR 5/20 column as described in Materials and Methods . Fig . 2 shows that eluted fractions between pH 5.5 and 6 .1 contained the bulk of TNF-a INH activity.
Experiments were performed to establish whether the TNF-a INH activity was due to a protein . Heating of Sephacryl S-200 semi-purified TNF-a INH at 56, 75, and 95°C reduced its activity in a time-and temperature-dependent fashion (Table I) . In another experiment, trypsin digestion for 24 h at 37°C reduced the inhibitory activity by -60% (Table I ). The possibility still remained that a molecule of low molecular weight binding to a protein was the active moiety of the inhibitory activity. Consequently, 1 ml of Sephacryl S-200 fraction was adjusted to 2 M urea and extensively dialyzed at 4°C against PBS containing 2 M urea. This material was dialyzed against PBS again before the bioassay ; the inhibitory activity was found to be unaffected (data not shown) .
We next investigated whether an excess of TNF-a was capable of overcoming the effect of the inhibitor . A consistent amount (25 gl) of Sephacryl S-200
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Fraction number FIGURE 1 . Urinary TNF-a INH activity profile of Sephacryl S-200 gel filtration . Urine of febrile patients was concentrated, ammonium sulfate-precipitated, and passed through molecular sieve chromatography as described in Materials and Methods. Column fractions were tested at 1 :10 dilution for effect in the hrTNF-a (1 .0 ng/ml) cytotoxicity assay in the presence of actinomycin D (1 ug/ml) (o). Bars represent cell lysis measured by dye uptake at 570 nm in response to actinomycin D(E)) and to actinomycin D plus hrTNF-a (O)without urine. Molecular weight markers are dextran blue (DB) ; BSA; OVA; a-chymotrypsinogen-A (aCT); RNase, and phenol-red ((h-red) .
Fraction number FIGURE 2. Urinary TNF-a INH activity profile of chromatofocusing Mono P column . Urine of febrile patients was concentrated, ammonium sulfate precipitated, and chromatofocussed as described in Materials and Methods. Column fractions (1 .0 ml) were tested at 1 :10 dilution for the effect in hrTNF-a (0 .2 ng/ml) cytotoxicity assay in the presence of actinomycin D (1 jug/ml) (o). Bars represent cell lysis measured by dye uptake at 570 nm in response to actinomycin D (p) and to actinomycin D plus hrTNF-a (m) without urine samples. semipurified inhibitor (equivalent to 1 :10 final dilution on cells) was added to increasing amounts of hrTNF-a. As shown in Fig . 3 , there was an inverse correlation between the amount of hrTNF-a present in the assay and the degree of inhibition observed . Thus, the inhibitory activity was competitively overcome by increasing concentrations of hrTNF-a .
Discussion
We have found that when tested in a cytotoxicity assay, urine from febrile patients contained a TNF-a inhibitory activity whose nature remains to be determined by purification to homogeneity, many bands being still identified in SDS-PAGE of the Sephacryl S-200 inhibitory fractions . Purification will enable us to establish a relationship with one or more other putative inhibitors . Thus, uromodulin, which binds TNF as well as IL-1, had no inhibitory activity when tested in our cytotoxicity assay, even at final concentrations as high as 2 ug/ml. Primary characterization indicates that the inhibitory activity is due to a protein, as it is sensitive to trypsin and pronase, with a pI ranging from 6.1 to 5.5 and an apparent mol wt of 40-60 X 103. This argues against the hypothesis that denatured TNF is responsible for the TNF-a INH activity by displacing the active native TNF-a from its receptor. Using a Western blotting technique, after a run of the semipurified Sephadex S-200 inhibitory fraction on SDS-PAGE under reducing conditions, no reactivity for any mol wt <26 X 103 was seen with polyclonal goat antisera raised against hrTNF-a (a gift from R. V. Ulevitch, Scripps Clinic) . Thus, neither a TNF-a precursor nor denatured TNF seems to be responsible for TNF-a INH activity . The TNF-a INH activity shows heat sensitivity, whereas it is fully maintained after urea treatment, eliminating the possibility that a small molecule is responsible for the TNF-a inhibition.
The results indicate that the inhibitor is specific for TNF-a and not due to an actinomycin D binding protein, as TNF-a INH activity was entirely overcome by increasing TNF-a concentrations without changing that of actinomycin D. Our data suggest a competitive mechanism of action perhaps situated at the receptor level itself, as is the case with the IL-1 INH previously observed in urine of similar patients (7, 8, 10) . It should be emphasized that urine from some febrile patients seems to be an important source of either IL-1 or TNF-a inhibitory activities and that, in analogy to the IL-1 INH, the relationship between TNF-a INH or IL-1 INH activities and disease still remains to be investigated . The question as to whether the present TNF-a INH is also effective against other bioactivities induced by TNF-a has already been approached, and it has been shown that the PGE2 production induced by TNF-a on human fibroblasts may well be inhibited by the present TNF-a INH (manuscript in preparation), which means that it is also effective on non-actinomycin D-treated cells . The present TNF-a INH differs unequivocally from the IL-1 inhibitor, since the latter did not inhibit TNF-a-induced cytotoxicity to murine L929 cells. Moreover, the TNF-a INH shows a higher molecular weight and does not inhibit the binding of ' 25I-IL-la to the murine thymoma subline EL4-6 .1 . Like the IL-1 INH, the TNF-a INH is a nonspecies-specific inhibitor as it acts on a murine cell line .
